Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 501426Generated: October 29, 2026

Salicylamide → 2-[7-(2-Butynyl)-1-methyl-8-(3-methylaminopiperidin-1-yl)-6-oxo-6,7-dihydro-1H-purin-2-yloxy]benzamide hydrochloride

https://huagongshe.com/reaction/501426

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSalicylamideHCID 5147—
ReactantPotassium CarbonateHCID 11430—
Reactant8-(3-Aminopiperidin-1-yl)-7-(2-butynyl)-1-(2-cyanobenzyl)-6-oxo-6,7-dihydro-1H-purine-2-carbonitrile hydrochlorideHCID 23070665—
Reactantt-butyl N-[1-[7-(2-butynyl)-2-chloro-1-methyl-6-oxo-6,7-dihydro-1H-purin-8-yl]piperidin-3-yl]-N-methylcarbamateHCID 57472749—
SolventN-methyl-2-pyrrolidoneHCID 13387—
Product2-[7-(2-Butynyl)-1-methyl-8-(3-methylaminopiperidin-1-yl)-6-oxo-6,7-dihydro-1H-purin-2-yloxy]benzamide hydrochlorideHCID 23070829—

Reaction Conditions

Temperature80 °C

Reaction Steps

A mixture consisting of 20 mg of t-butyl N-[1-[7-(2-butynyl)-2-chloro-1-methyl-6-oxo-6,7-dihydro-1H-purin-8-yl]piperidin-3-yl]-N-methylcarbamate, 20 mg of 2-hydroxybenzamide, 20 mg of anhydrous potassium carbonate, and 0.3 ml of N-methyl-2-pyrrolidone was stirred in an oil bath at 80° C. for 4 hours. Subsequent synthesis steps were carried out according to the same procedure as used in Examples 242(f) and (g) to give the title compound.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07772226B2
Source datasetuspto-grants-2010_08
ORD IDord-982186c7eb6b49938322553db68f6991
Source noteuspto-grants-2010_08